provid
inform
singl
viru
particl
long
time
mainli
domain
electron
microscopi
recent
technolog
developedor
adapt
field
nanotechnologyto
allow
realtim
quantif
physic
virion
particl
suppli
addit
inform
particl
diamet
concomitantli
technolog
progress
stage
commerci
increas
speed
viral
titer
measur
hour
minut
thu
provid
signific
advantag
mani
aspect
virolog
research
biotechnolog
applic
addit
advantag
lie
broad
spectrum
viru
speci
may
measur
possibl
determin
ratio
infecti
total
particl
seri
disadvantag
remain
associ
technolog
low
specif
viral
particl
review
discuss
technolog
compar
four
system
realtim
singl
viru
particl
analysi
quantif
basic
research
emerg
viral
diseas
clinic
applic
viral
gene
therapi
vectorsit
often
vital
quantifi
viral
amount
accur
consequ
wide
spectrum
method
use
determin
viru
concentr
may
group
broadli
four
categori
determin
level
infect
b
measur
presenc
function
viral
protein
c
detect
presenc
viral
marker
nucleic
acid
within
viral
genom
count
physic
viral
particl
whether
label
unmark
see
tabl
method
determin
infect
level
includ
measur
cytopath
effect
plaqu
form
tissu
cultur
infecti
dose
tcid
assay
also
flow
cytometr
measur
cellular
transduct
infect
viral
particl
carri
report
gene
green
fluoresc
protein
metzner
et
al
papanikola
et
al
hemagglutin
assay
directli
measur
propens
viral
protein
crosslink
suscept
cell
type
serolog
methodolog
also
measur
presenc
viral
antigen
albeit
indirectli
determin
antibodi
convers
gener
use
antibodi
technolog
great
impact
viru
quantif
sinc
high
specif
sensit
achiev
ie
enzymelink
immunosorb
assay
elisa
format
howev
stringenc
elisa
approach
viru
quantif
consid
low
measur
viral
element
necessarili
link
viru
particl
see
tabl
even
consider
faster
cellcultur
base
method
take
hour
complet
assay
advent
molecular
techniqu
especi
polymeras
chain
reaction
pcr
also
left
mark
quantif
viral
particl
rna
dna
level
measur
use
quantit
pcr
approach
absolut
quantif
ie
copi
number
number
particl
obtain
rel
raw
data
use
standard
dilut
vector
dna
rna
pcr
may
also
use
quantifi
protein
level
productenhanc
revers
transcriptas
pert
assay
product
dna
viral
rna
revers
transcriptas
present
retrovir
sampl
quantifi
use
turn
estim
viru
particl
concentr
metzner
et
al
pcr
protein
detect
method
offer
advantag
term
time
need
get
result
compar
cellcultur
base
method
inde
cultur
necessari
constitut
signific
advantag
sinc
cultur
may
possibl
case
nevertheless
stringenc
techniqu
also
consid
low
measur
viral
elementin
case
nucleic
acidi
necessarili
part
avirion
infecti
otherwis
calcul
may
significantli
overestim
number
particl
present
see
tabl
fig
analysi
singl
viru
particl
long
remit
electron
microscopi
recent
technic
progress
field
microscopi
well
adapt
applic
origin
develop
use
nanotechnolog
cross
use
virolog
made
quantit
analysi
singl
viral
particl
physic
entiti
feasibl
technolog
includ
atom
forc
microscopi
afm
ohnesorg
et
al
laser
light
scatter
applic
multipleangl
laser
light
scatter
mall
bouss
et
al
wei
et
al
nanoparticl
track
analysi
nta
papanikola
et
al
filip
et
al
kramberg
et
al
anderson
et
al
du
et
al
tunabl
resist
puls
sens
trp
method
base
coulter
principl
vogel
et
al
farka
et
al
rybakova
et
al
flow
cytometri
fc
variant
brussaard
et
al
ferri
et
al
stepp
et
al
stepp
et
al
kemp
et
al
method
appear
fall
categori
discuss
greater
detail
viral
quantit
capillari
electrophoresi
vqce
mironov
et
al
sinc
correl
particl
count
nucleic
acid
amount
use
calcul
viru
titer
similar
qpcr
rather
presenc
virion
particl
howev
vqce
special
interest
sinc
abl
distinguish
intact
viru
fraction
free
dna
mironov
et
al
interest
aspect
tri
evalu
pcr
base
quantif
data
review
concentr
technolog
show
promis
field
progress
stage
commerci
avail
name
fieldflow
fraction
fff
mall
nta
flow
virometri
use
viruscount
vc
devic
trp
see
tabl
fffmall
equip
offer
wyatt
technolog
http
www
wyattcom
combin
separ
step
use
variant
fff
detect
step
use
mall
fff
liquid
chromatographi
techniqu
sampl
separ
occur
laminar
flow
channel
column
media
interact
sampl
particl
elut
order
increas
size
separ
sampl
rapid
gentl
elut
particl
detect
mall
provid
simultan
detect
light
scatter
sever
angl
provid
addit
inform
compar
laser
light
scatter
approach
measur
intens
angular
depend
scatter
laser
light
possibl
deduc
radiu
particl
ie
determin
size
distribut
chuan
et
al
peas
et
al
subsequ
calcul
number
particl
per
volum
bouss
et
al
wei
et
al
fffmall
data
compar
measur
infect
level
qpcr
influenza
prepar
sampl
rang
sourc
follow
vaccin
product
procedur
highest
valu
determin
observ
qpcr
measur
follow
result
fffmall
measur
correl
infect
bouss
et
al
wei
et
al
see
also
tabl
measur
infect
stringent
method
result
could
expect
see
also
tabl
similar
comparison
differ
method
measur
tabl
method
viru
quantif
tabl
summar
common
method
use
quantif
viru
tissu
cultur
infecti
dose
elisa
enzymelink
immunosorb
assay
pertproductenhanc
revers
transcriptas
assay
sridsingl
radial
immunodiffus
assay
rt
qpcr
revers
transcriptas
quantit
polymeras
chain
reaction
ntananoparticl
track
analysi
vcviruscount
trpstunabl
resist
puls
sens
fffmallsfieldflow
fraction
multipleangl
laser
light
scatter
afmatom
forc
microscopi
minuteshour
medium
lentivir
count
qpcr
indic
higher
concentr
particl
base
approach
compar
fig
believ
result
differ
requir
measur
qpcr
nucleic
acid
need
present
fffmal
trp
part
viru
need
come
togeth
combin
separ
purif
step
prior
detect
promis
concept
singl
particl
quantif
approach
sinc
sampl
puriti
crucial
precis
measur
current
effort
term
technic
expertis
equip
higher
compar
techniqu
howev
mostli
due
two
differ
technolog
implement
separ
nanoparticl
track
analysi
nta
develop
nanosight
ltd
wwwnanosightcom
recent
acquir
malvern
instrument
ltd
realtim
nanoparticl
visual
base
laserillumin
microscop
techniqu
laser
beam
pass
optic
prism
result
refract
use
compress
beam
intens
illumin
region
nanoparticl
visual
brownian
motion
nanoparticl
ie
viru
particl
liquid
detect
either
chargecoupl
devic
ccd
camera
recent
complementari
metaloxidesemiconductor
cmo
sensor
base
system
transform
optic
inform
electron
data
modern
cmo
sensor
process
frame
per
second
thu
well
suit
applic
video
captur
camera
show
movement
individu
particl
subsequ
analyz
use
nta
softwar
automat
calcul
distanc
particl
move
know
temperatur
viscos
solvent
particl
diamet
calcul
use
variat
stokeseinstein
equat
depend
refract
index
r
nanoparticl
lower
size
limit
detect
method
rang
nm
particl
high
r
colloid
gold
nm
lower
r
particl
biolog
origin
upper
size
limit
determin
brownian
motion
movement
becom
limit
track
accur
particl
reach
approxim
mm
diamet
nta
approach
measur
singl
particl
simultan
suffici
number
particl
analyz
accord
manufactur
claim
import
factor
make
possibl
sampl
contain
particl
per
ml
quantif
usual
need
sampl
unknown
concentr
dilut
step
need
reach
quit
small
gap
may
result
signific
longer
time
need
sampl
prepar
therefor
time
taken
per
measur
may
vari
min
h
filip
et
al
sever
group
tri
investig
use
nanosight
devic
viral
particl
quantif
mironov
et
al
publish
techniqu
provid
good
indic
particl
per
volum
measur
vaccinia
viru
sampl
although
quickli
reach
technic
limit
host
cell
debri
background
particl
present
indic
need
effici
viru
sampl
purif
strategi
nanosight
perform
also
extend
label
viru
particl
fluorophor
discrimin
host
cell
debri
identifi
specif
viru
speci
inform
see
http
www
nanosightcomtechnologyfluorescencecap
although
particlebas
method
unabl
distinguish
infecti
noninfecti
particl
label
ie
viral
protein
mediat
cell
entri
may
option
increas
stringenc
method
anderson
et
al
correl
nanosight
result
plaqu
assay
quantit
pcr
quantifi
bacteriophag
conclud
less
precis
provid
result
quickli
within
min
drawback
face
nta
work
phage
sampl
suspend
clear
medium
also
comment
high
price
equip
rel
small
concentr
rang
accur
result
could
gener
nevertheless
state
nta
base
method
optim
like
reproduc
accuraci
compar
plaqu
assay
significantli
faster
adenovir
prepar
analyz
use
cytopath
effect
base
cell
cultur
assay
nta
result
vari
two
three
log
case
nanosight
measur
yield
higher
valu
kramberg
et
al
see
also
tabl
group
use
hemagglutinin
ha
titrat
nta
quantif
influenza
prepar
kramberg
et
al
particl
number
howev
deriv
ha
valu
sinc
appropri
standard
allow
absolut
quantif
miss
thu
direct
comparison
infecti
total
particl
possibl
case
lentivir
vector
pseudotyp
vesicular
stomat
viru
g
vsvg
protein
analyz
use
flow
cytometri
report
gene
type
paramet
measur
influenc
stringenc
thu
level
titer
measur
measur
infect
alway
give
lower
titer
measur
particl
number
protein
nucleic
acid
amount
base
measur
case
infecti
titer
measur
flow
cytometri
report
gene
transduct
total
particl
number
measur
trp
revers
transcriptas
level
measur
pert
assay
viral
rna
contain
gfp
report
measur
rt
qpcr
determin
triplic
differ
prepar
lentivir
particl
deriv
stabl
produc
cell
line
starahv
ecacc
viral
prepar
concentr
ultracentrifug
h
beckmann
ultracentrifug
use
rotor
concentr
prepar
shown
togeth
respect
mean
standard
error
mean
sem
trpstunabl
resist
puls
sens
pertproductenhanc
revers
transcriptas
assay
qpcrquantit
polymeras
chain
reaction
b
averag
vs
distribut
two
distribut
depict
clearli
distinct
yield
averag
indic
vertic
dot
line
use
ensembl
method
subpopul
may
hidden
indic
import
singl
particl
analysi
transduct
nanosight
nascent
virion
found
infect
papanikola
et
al
see
also
tabl
provid
import
inform
qualiti
vector
prepar
addit
nta
total
particl
titer
fluoresc
tag
noninfecti
viruslik
particl
shown
good
agreement
measur
base
electron
microscopi
elisa
respect
gutierrez
cervera
et
al
recent
nta
use
compar
size
amount
human
cytomegaloviru
hcmv
virion
dens
bodi
db
type
noninfecti
particl
produc
hcmv
cayatt
et
al
virocyt
http
wwwvirocytcom
develop
flow
cytometerlik
devic
viruscount
vc
suitabl
viru
quantif
liquid
sampl
recent
modifi
version
devic
present
better
suit
industri
applic
info
see
http
virocytcomnewsnewrapidviruscoun
tersystemintroducedatworldvaccinecongress
vc
use
two
separ
fluoresc
dye
stain
viru
sampl
one
specif
protein
nucleic
acid
certain
size
viru
nm
certain
length
viral
genom
ntbp
necessari
guarante
suffici
level
stain
inform
price
pleas
contact
manufactur
refer
bouss
et
al
wei
et
al
chuan
et
al
peas
et
al
papanikola
et
al
kramberg
et
al
du
et
al
gutierrezgranado
et
al
cervera
et
al
cayatt
et
al
ferri
et
al
stepp
et
al
stepp
et
al
kemp
et
al
vogel
et
al
farka
et
al
rybakova
et
al
brussaard
et
al
accord
manufactur
b
accord
bouss
et
al
c
accord
http
wwwnanosightcomtechnologyfluorescencecap
measur
ratio
total
infecti
particl
ratio
total
infecti
particl
ffffieldflow
fraction
ntananoparticl
track
analysi
vcviruscount
trpstunabl
resist
puls
sens
detect
event
posit
channel
count
viral
particl
nonspecif
stain
process
elimin
need
targetspecif
reagent
fluorescencelabel
antibodi
requir
convent
flowcytometri
method
therefor
costeffect
schulzehorsel
et
al
stain
proteinnucl
acid
also
reduc
signal
inorgan
contamin
ie
nanos
salt
precipit
buffer
solut
vc
method
mention
review
reli
label
measur
may
introduc
nonspecif
stain
signal
gener
label
procedur
may
chang
sampl
properti
diamet
zeta
potenti
increas
time
measur
howev
fluoresc
measur
stain
viru
particl
requir
min
incub
subsequ
analysi
accomplish
around
min
per
sampl
accord
manufactur
document
trial
run
author
measur
time
gener
shorter
min
viral
particl
concentr
calcul
number
particl
gener
posit
event
channel
sampl
flow
rate
rang
reliabl
measur
n
n
viru
particl
per
ml
fffmal
nta
trp
current
research
group
test
andor
evalu
vc
stepp
et
al
determin
tcid
concentr
transmiss
electron
microscopi
tem
compar
result
measur
vc
broad
rang
viru
speci
adenovia
herp
simplex
parainfluenzaviru
see
also
tabl
could
show
good
agreement
differ
measur
method
ferri
et
al
gener
recombin
baculoviru
sampl
test
hous
plaqu
assay
subsequ
sent
collabor
perform
plaqu
assay
measur
vc
deblind
abl
show
vc
provid
statist
signific
resultsdetermin
linear
regress
analysi
logtransform
averag
result
pearson
correl
analysisto
plaqu
assay
consider
advantag
term
time
need
get
result
vc
also
use
control
viral
titer
baculovirusbas
express
system
kemp
et
al
influenza
sampl
investig
viru
concentr
use
tcid
em
vc
titer
particl
per
ml
respect
also
case
rel
big
gap
infecti
total
particl
number
observ
gener
two
reason
contribut
differ
infecti
total
viru
count
cell
produc
particl
resembl
viru
infecti
either
consequ
viral
infect
ie
hepat
b
consequ
cellular
physiolog
process
ie
exosom
ii
artefact
prepar
contribut
gap
format
aggreg
increas
total
particl
count
loss
infect
may
occur
prepar
procedur
exampl
lentivir
particl
use
trp
studi
particularli
prone
latter
see
fig
ultracentrifug
neg
affect
molecul
respons
viral
entri
tunabl
resist
puls
sens
trp
origin
term
scan
ion
occlus
sens
sio
technolog
behind
qnano
qvirox
devic
market
izon
ltd
wwwizoncom
util
stretchabl
membran
achiev
sizeadjust
nanopor
count
measur
size
particl
pass
pore
vogel
et
al
addit
measur
zetapotenti
possibl
kozak
et
al
paramet
describ
electrokinet
potenti
colloid
system
provid
inform
similar
charg
data
help
predict
attach
behavior
stabil
viral
prepar
zhang
et
al
arjmandi
et
al
adjust
pore
central
part
techniqu
offer
possibl
measur
particl
rang
nm
mm
thu
exclud
smaller
viru
famili
pore
locat
elast
polyurethan
center
cruciform
support
place
within
fluid
cell
qvirox
instrument
stretch
membran
mechan
pore
sizeadjust
accord
individu
need
fluid
cell
character
agagcl
electrod
local
upper
lower
compart
cell
use
appli
potenti
differ
across
pore
build
electrolyt
fluid
bridg
current
across
pore
measur
qvirox
softwar
sampl
appli
upper
compart
fluid
cell
particl
pass
pore
socal
blockad
event
ionic
current
creat
lead
resist
puls
linear
relationship
particl
volum
fundament
applic
coulter
principl
particl
pass
pore
due
charg
weakli
charg
neutral
particl
possibl
appli
pressur
order
increas
flow
particl
pore
also
help
tool
measur
sampl
low
concentr
qvirox
calibr
carboxyl
polystyren
particl
defin
size
known
concentr
sampl
analyz
condit
size
distribut
calcul
use
comparison
blockad
magnitud
distribut
calibr
particl
unknown
sampl
vogel
et
al
trp
report
abl
measur
particl
size
size
distribut
nanoparticl
good
accuraci
precis
sensit
sever
differ
nanoparticl
includ
silica
nanoparticl
dnacoat
nanoparticl
adenoviru
liposom
yang
et
al
one
group
test
qvirox
size
measur
concentr
measur
adenoviru
sampl
drew
conclus
size
measur
trp
good
agreement
electron
microscopi
result
vogel
et
al
vogel
et
al
describ
nanopor
standard
particl
use
detail
analyz
em
describ
reproduc
size
measur
standard
particl
rang
membran
stretch
group
trp
use
quantifi
lentivir
particl
deriv
stabl
lentivir
produc
cell
line
call
starahv
ikeda
et
al
result
show
measur
particl
concentr
particl
per
ml
consider
higher
infecti
titer
particl
per
ml
lower
result
pert
particl
per
ml
rtqpcr
protocol
particl
per
ml
see
also
fig
tabl
indic
nascent
virion
infecti
repres
decreas
compar
result
achiev
vsvg
pseudotyp
lentivirus
nta
measur
papanikola
et
al
like
due
less
stabl
amphotrop
murin
leukemia
viru
mlv
env
present
starahvderiv
viral
particl
inde
use
sucros
cushion
concentr
prepar
infecti
titer
improv
averag
tenfold
unpublish
data
howev
comparison
difficult
sinc
differ
method
particl
quantif
use
addit
work
done
group
trp
use
quantifi
rotaviru
particl
result
studi
also
suggest
gross
overestim
rotaviru
particl
due
empti
capsid
cellular
debri
farka
et
al
indic
method
great
care
given
sampl
prepar
nanopor
get
clog
crude
sampl
use
hand
trp
membran
tend
block
easili
vc
fluidicsan
issu
may
rectifi
chang
properti
membran
surfac
ie
coat
low
adsorpt
materi
bacteriophag
taillik
particl
also
quantifi
trp
rybakova
et
al
indic
form
particl
affect
measur
trp
also
use
analyz
interact
two
element
particl
biosens
applic
http
wwwizoncomapplicationsbiodiagnost
goldnanoparticlesforbiosens
follow
size
distribut
may
repres
possibl
specif
detect
similar
use
immunogold
stain
electron
microscopi
antibodyfunction
nanoparticl
could
associ
viral
sampl
subsequ
increas
particl
size
would
demonstr
specif
interact
nanoparticl
viru
particl
http
wwwizoncomcapabilitiesparticleinterac
tionmonitor
qvirox
smallest
bench
footprint
devic
mention
easili
transport
importantli
quantit
singl
particl
assay
reli
paramet
devoid
biolog
connot
except
proteinnucl
acid
label
vc
quantif
viru
particl
contrast
establish
viru
quantif
method
base
infect
protein
nucleic
acid
level
howev
inform
ultim
present
number
particl
per
volum
process
infer
inform
give
rise
inher
differ
compar
result
type
inform
see
fig
exampl
infecti
titer
whether
measur
plaqu
assay
level
cellular
transduct
marker
protein
case
fig
alway
give
lower
concentr
method
base
presenc
nucleic
acid
protein
particl
see
also
tabl
explain
level
stringenc
associ
measur
paramet
protein
nucleic
acid
base
method
presenc
said
factor
alon
enough
measur
infect
element
viru
need
place
correctli
allow
infect
measur
presenc
particl
somehow
lie
factor
make
viru
need
correct
shape
form
aggreg
howev
function
requir
effect
even
exagger
fig
sinc
crude
ultracentrifug
protocol
use
larg
destroy
infect
capabl
lentivir
particl
pseudotyp
mlv
amphotrop
envelop
protein
addit
pert
assay
rtqpcr
trp
use
quantifi
eight
differ
prepar
triplic
shown
fig
case
stringenc
trp
seem
tenfold
higher
pert
qpcr
similar
result
obtain
influenza
sampl
investig
use
tcid
em
vc
viru
quantif
also
influenza
compar
fffmal
data
infecti
titer
correl
qpcr
confirm
analysi
adenoviru
sampl
nta
method
kramberg
et
al
see
tabl
overview
howev
differ
measur
principl
make
possibl
investig
import
question
virolog
cell
may
produc
vast
quantiti
physic
viral
particl
portion
fulli
infecti
ibiricu
et
al
meck
raabtraub
noninfecti
particl
produc
upon
viral
infect
contribut
viral
spread
numer
way
ie
provid
immun
decoy
compar
differ
type
vesicl
ie
accord
size
use
describ
technolog
possibl
describ
dens
bodi
produc
hcmv
infect
cell
cayatt
et
al
gene
therapi
percentag
infecti
particl
given
viral
vector
stock
significantli
influenc
efficaci
gene
transfer
thu
main
paramet
vector
stock
qualiti
control
method
present
capabl
measur
total
viru
particl
thu
allow
determin
total
infecti
particl
ratio
ratio
see
tabl
anoth
open
question
concern
relationship
viral
particl
product
especi
case
envelop
virus
product
lipid
vesicl
similar
size
rang
exosom
meck
raabtraub
raposo
stoorvogel
may
contribut
particl
count
infect
level
common
contamin
viral
prepar
cantin
et
al
exosom
recent
garner
greater
degre
interest
function
celltocel
commun
also
potenti
use
sourc
biomark
properzi
et
al
gene
deliverytherapi
vector
elandaloussi
et
al
gener
interplay
viru
particl
exosom
interest
topic
meck
raabtraub
wurding
et
al
singleparticl
analysi
techniqu
includ
nta
elandaloussi
et
al
twu
et
al
trp
de
vrij
et
al
ng
et
al
also
use
character
exosom
singleparticl
analysi
techniqu
also
allow
addit
paramet
measur
viru
diamet
charg
respect
inher
advantag
singl
particl
analysi
distribut
distinct
valu
rather
averag
gener
averag
data
may
hide
subpopul
see
fig
import
answer
research
question
exampl
discrimin
exosom
viral
particl
addit
measur
size
distribut
help
determin
aggreg
state
particl
solut
import
paramet
sever
applic
ie
assess
qualiti
viral
vector
gene
therapi
vaccin
prepar
aggreg
data
deriv
affmal
data
influenza
wei
et
al
nta
measur
lentivir
prepar
papanikola
et
al
trp
experi
use
investig
aggreg
adenovir
sampl
vogel
et
al
depict
size
distribut
histogram
allow
easi
interpret
papanikola
et
al
vogel
et
al
addit
size
distribut
inform
zeta
potenti
measur
help
sinc
particl
higher
zeta
potenti
ie
mv
repuls
readili
thu
increas
monodispers
prepar
gener
averag
vs
distribut
topic
resembl
differ
result
immunoblot
analysi
flow
cytometri
first
provid
inform
averag
presenc
protein
interest
cell
latter
provid
inform
distribut
cell
virus
compris
sampl
advantag
share
method
time
take
sampl
analysi
measur
minut
rather
day
hour
see
tabl
particl
number
count
directli
infer
infect
protein
nucleic
acid
level
need
cultur
viral
particl
potenti
broad
rang
virus
measur
technolog
method
contribut
inform
determin
ratio
total
infecti
particl
similar
level
stringenc
howev
problem
also
share
differ
techniqu
peerreview
literatur
still
scarc
sampl
preparationmostli
filtrat
remov
larger
particul
materiali
vital
ensur
optim
measur
condit
determin
devic
ie
avoid
block
fluidic
met
keep
contamin
level
low
measur
determin
background
nois
level
buffer
also
critic
measur
use
singl
particl
detect
moder
stringenc
specif
fffmal
trp
nta
measur
presenc
particl
specif
size
rang
may
viru
particl
exosom
cellular
debri
appropri
size
inorgan
contamin
buffer
indic
strong
influenc
sampl
prepar
result
subsequ
measur
complex
sampl
matric
serum
difficult
vc
partial
address
problem
stain
viral
particl
nucleic
acid
protein
may
distinguish
viral
particl
cellular
debri
inorgan
contamin
may
suffici
discrimin
viru
exosom
carri
protein
rna
requir
possibl
label
viru
specif
ie
use
fluoresc
tag
antibodi
detect
parallel
along
usual
paramet
alreadi
implement
nta
may
easili
implement
vc
sinc
fluoresc
detect
alreadi
place
current
potenti
highthroughput
measur
limit
mean
option
measur
sever
sampl
parallel
lack
howev
recent
version
vc
includ
compat
autosampl
also
combin
fraction
detect
suggest
fffmal
system
may
make
handl
easier
allow
better
estim
contamin
level
gener
handl
requir
experi
oper
aspect
vc
system
may
prove
robust
multipl
addit
paramet
size
charg
zeta
potenti
particl
measur
trp
kozak
et
al
fffmal
wei
et
al
nta
kramberg
et
al
vc
interest
tri
find
subpopul
viral
prepar
ie
qualiti
control
viral
vector
vaccin
product
identifi
contamin
aggreg
event
compar
cost
differ
system
somehow
difficult
one
hand
price
devic
may
vari
consider
depend
condit
purchas
agreement
specif
devic
setup
eg
three
differ
setup
avail
nta
two
devic
avail
vc
hand
cost
consum
taken
consider
mainli
membran
contain
nanopor
trp
fluoresc
label
cocktail
vc
measur
contact
manufactur
cost
devic
consum
therefor
indispens
howev
final
question
still
remain
method
choos
order
quantifi
viru
particl
unfortun
clear
singl
answer
availablesinc
suffici
compar
data
use
differ
system
lackingexcept
combin
quantit
realtim
singl
particl
analysi
method
like
provid
import
support
inform
ultim
access
equip
may
determin
choic
technolog
